Apex Healthcare Berhad (KLSE:AHEALTH) - Prezzo delle azioni, notizie e analisi

AHEALTH Panoramica delle azioni

AHEALTH analisi fondamentale
Punteggio fiocco di neve
Valutazione	1/6
Crescita futura	2/6
Prestazioni passate	2/6
Salute finanziaria	6/6
Dividendi	5/6

Premi

Si prevede che gli utili cresceranno del 9.43% all'anno

Analisi del rischio

I margini di profitto (9.3%) sono inferiori rispetto allo scorso anno (45.5%)

Il dividendo di 10.08% non è ben coperto dai flussi di cassa liberi

Apex Healthcare Berhad Concorrenti

Duopharma Biotech Berhad

KLSE:DPHARMA

RM 1.2b

Kotra Industries Berhad

KLSE:KOTRA

RM 639.2m

Y.S.P. Southeast Asia Holding Berhad

KLSE:YSPSAH

RM 317.7m

Rhone Ma Holdings Berhad

KLSE:RHONEMA

RM 152.6m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Apex Healthcare Berhad
Prezzi storici delle azioni
Prezzo attuale dell'azione	RM 2.58
Massimo di 52 settimane	RM 3.42
Minimo di 52 settimane	RM 2.38
Beta	0.31
1Variazione di 1 mese	-3.37%
Variazione a 3 mesi	-6.18%
Variazione di 1 anno	6.17%
3Variazione a 3 anni	47.15%
Variazione a 5 anni	64.68%
Variazione dall'IPO	1,177.54%

Notizie e aggiornamenti recenti

Recent updates

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

May 08

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Aug 28

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apr 19

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Feb 25

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Aug 24

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

May 11

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

Feb 11

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Jan 25

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Jan 07

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Dec 20

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

Dec 05

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Nov 20

Rendimenti per gli azionisti

	AHEALTH	MY Pharmaceuticals	MY Mercato
7D	-0.8%	-0.2%	-0.03%
1Y	6.2%	-0.4%	10.4%

Ritorno vs Industria: AHEALTH ha superato il MY Pharmaceuticals che ha restituito -0.4 % nell'ultimo anno.

Rendimento vs Mercato: AHEALTH ha avuto una performance inferiore al mercato MY che ha registrato un rendimento 10.4 % nell'ultimo anno.

Volatilità dei prezzi

Is AHEALTH's price volatile compared to industry and market?
AHEALTH volatility
AHEALTH Average Weekly Movement	1.8%
Pharmaceuticals Industry Average Movement	3.6%
Market Average Movement	5.1%
10% most volatile stocks in MY Market	10.3%
10% least volatile stocks in MY Market	2.6%

Prezzo delle azioni stabile: AHEALTH non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 2% ) di AHEALTH è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1962	976	Kirk Kee	www.apexhealthcare.com.my

Apex Healthcare Berhad, una holding di investimento, si occupa di sviluppo, produzione, commercializzazione, distribuzione e vendita all'ingrosso di prodotti farmaceutici e sanitari in Malesia, a Singapore e a livello internazionale. Opera attraverso tre segmenti: Produzione, Distribuzione e Corporate. L'azienda offre una gamma di prodotti, tra cui miscele per la tosse e antistaminici, antinfettivi, antidiabetici, antipertensivi, agenti neuromuscolari, analgesici, dermatologici e oftalmologici sotto forma di compresse, capsule, liquidi e sospensioni orali, creme e colliri sterili con il marchio Xepa.

Apex Healthcare Berhad Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Apex Healthcare Berhad con la sua capitalizzazione di mercato?
AHEALTH statistiche fondamentali
Capitalizzazione di mercato	RM 1.86b
Guadagni(TTM)	RM 89.08m
Ricavi(TTM)	RM 962.25m

20.9x

Rapporto P/E

1.9x

Rapporto P/S

AHEALTH è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
AHEALTH Conto economico (TTM)
Ricavi	RM 962.25m
Costo del fatturato	RM 743.36m
Profitto lordo	RM 218.90m
Altre spese	RM 129.82m
Guadagni	RM 89.08m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	0.12
Margine lordo	22.75%
Margine di profitto netto	9.26%
Rapporto debito/patrimonio netto	0.09%

Come si è comportato AHEALTH nel lungo periodo?

Vedi performance storica e confronto

Dividendi

10.1%

Rendimento attuale del dividendo

40%

Rapporto di remunerazione

AHEALTH Panoramica delle azioni

Premi

Analisi del rischio

Apex Healthcare Berhad Concorrenti

KLSE:DPHARMA

RM 1.2b

KLSE:KOTRA

RM 639.2m

KLSE:YSPSAH

RM 317.7m

KLSE:RHONEMA

RM 152.6m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

First half dividend increased to RM0.03

Second quarter 2024 earnings released: EPS: RM0.033 (vs RM0.46 in 2Q 2023)

Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2024, Payable on September 18, 2024

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

First quarter 2024 earnings released: EPS: RM0.03 (vs RM0.034 in 1Q 2023)

Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023

Recent updates

First half dividend increased to RM0.03

Second quarter 2024 earnings released: EPS: RM0.033 (vs RM0.46 in 2Q 2023)

Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2024, Payable on September 18, 2024

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

First quarter 2024 earnings released: EPS: RM0.03 (vs RM0.034 in 1Q 2023)

Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

Upcoming dividend of RM0.23 per share

Full year 2023 earnings: EPS exceeds analyst expectations

Apex Healthcare Berhad, Annual General Meeting, May 15, 2024

Full year 2023 earnings released: EPS: RM0.56 (vs RM0.14 in FY 2022)

Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Third quarter 2023 earnings released: EPS: RM0.034 (vs RM0.038 in 3Q 2022)

Upcoming dividend of RM0.025 per share at 2.5% yield

Price target decreased by 7.3% to RM2.55

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023

Price target decreased by 7.8% to RM2.58

Second quarter 2023 earnings released: EPS: RM0.46 (vs RM0.033 in 2Q 2022)

Investor sentiment deteriorates as stock falls 36%

First quarter 2023 earnings released: EPS: RM0.051 (vs RM0.033 in 1Q 2022)

Upcoming dividend of RM0.055 per share at 2.3% yield

Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 15%

Full year 2022 earnings released: EPS: RM0.21 (vs RM0.13 in FY 2021)

Third quarter 2022 earnings released: EPS: RM0.057 (vs RM0.03 in 3Q 2021)

Insufficient new directors

Upcoming dividend of RM0.03 per share

Second quarter 2022 earnings released: EPS: RM0.05 (vs RM0.027 in 2Q 2021)

Apex Healthcare Berhad Declares an Interim Dividend, Payable on 15 September 2022

Price target increased to RM3.21

Upcoming dividend of RM0.09 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to RM3.07

Insufficient new directors

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Proposes Special Single-Tier Dividend for Financial Year Ended 31 December 2021, Payable on 16 June 2022

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Announces Special Dividend in Respect of the Financial Year Ended 31 December2021, Payable on 16 June 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Third quarter 2021 earnings released: EPS RM0.03 (vs RM0.03 in 3Q 2020)

Upcoming dividend of RM0.025 per share

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Second quarter 2021 earnings released: EPS RM0.027 (vs RM0.028 in 2Q 2020)

Upcoming dividend of RM0.028 per share

First quarter 2021 earnings released: EPS RM0.025 (vs RM0.03 in 1Q 2020)

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Is Apex Healthcare Berhad (KLSE:AHEALTH) A Smart Pick For Income Investors?

Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)

Does Apex Healthcare Berhad (KLSE:AHEALTH) Deserve A Spot On Your Watchlist?

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Revenue and earnings miss expectations

New 90-day low: RM3.32